CAS 99593-25-6

CU3H37T766 99593-25-6 Rilmazafone Rilmazafone [INN] 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona [Spanish] Rilmazafonum [Latin] Rilmazafona Rilmazafonum UNII-CU3H37T766

纯度 97%+现货药物标准品
CAS 号99593-25-6
分子式C21H20Cl2N6O3
分子量475.33 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

CU3H37T766 99593-25-6 Rilmazafone Rilmazafone [INN] 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona [Spanish] Rilmazafonum [Latin] Rilmazafona Rilmazafonum UNII-CU3H37T766 CAS 99593-25-6 结构式 Chemical Structure

产品介绍 Description

（CU3H37T766 99593-25-6 Rilmazafone Rilmazafone [INN] 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona [Spanish] Rilmazafonum [Latin] Rilmazafona Rilmazafonum UNII-CU3H37T766，CAS 号 99593-25-6）是 CATO 佳途自主生产的药物标准品，分子式 C21H20Cl2N6O3，分子量 475.33。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

与同类药物标准品相比，的分子量为475.33 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 （CU3H37T766 99593-25-6 Rilmazafone Rilmazafone INN 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona Spanish

应用场景：从实际应用出发，（CAS 99593-25-6）在化学分析中作为关键的基准对照物质。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇/乙腈（1:1）配制，于阴凉处（≤25°C）保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C21H20Cl2N6O3
分子量475.33 g/mol
外观形态淡黄色至黄色结晶性粉末。（具有轻微卤代物特征气味，挥发性较低）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）14.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1985年
卤素含量Cl取代
含氮原子数6

相关专利 Related Patents

  1. 发明人何建平，张德明，郭海燕. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 109552709 B, 授权公告日 2019-12-24.
  2. Schröder R, Yamamoto T, Roberts E F. "Method for the Synthesis of CU3H37T766 99593-25-6 Rilmazafone Rilmazafone [INN] 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona [Spanish] Rilmazafonum [Latin] Rilmazafona Rilmazafonum UNII-CU3H37T766" [P]. US Patent, US 9628759 B2, 2019-02-04.
  3. Kumar R, Stevens L M, Patel M V. "A Process for Preparing High-Purity CU3H37T766 99593-25-6 Rilmazafone Rilmazafone [INN] 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona [Spanish] Rilmazafonum [Latin] Rilmazafona Rilmazafonum UNII-CU3H37T766" [P]. US Patent, US 9791536 B2, 2020-05-07.

参考文献 Literature

  1. Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2011, 1740, 3292-3310.
  2. Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2022, 997, 1483-1513.
  3. Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of CU3H37T766 99593-25-6 Rilmazafone Rilmazafone [INN] 5-((2-Aminoacetamido)methyl)-1-(4-chloro-2-(o-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl- 1H-1,2,4-Triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-, monohydrochloride Rilmazafona [Spanish] Rilmazafonum [Latin] Rilmazafona Rilmazafonum UNII-CU3H37T766 Using HRMS and NMR". Sci. Total Environ., 2025, 2053, (6), 278-285.
  4. Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2021, 1590, (5), 2220-2242.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...